Saturday, December 20, 2025
ADVT 
International

China permits Indian students to return on 'need-assessed' basis

Darpan News Desk IANS, 29 Apr, 2022 12:10 PM
  • China permits Indian students to return on 'need-assessed' basis

New Delhi, April 29 (IANS) China has allowed return of Indian students to its various universities on a "need-assessed basis", according to the Indian Embassy in China.

According to the Embassy, following the meeting of External Affairs Minister S. Jaishankar with his Chinese counterpart Wang Yi on March 25, the Chinese side has expressed its willingness to consider facilitating the return of Indian students to China on a need-assessed basis.

In order to facilitate this, the Indian Embassy intends to prepare a list of such students which will be shared with the Chinese side for their consideration.

The embassy has come up with a form and requested Indian students to fill out citing their necessity.

Once the collated information is shared with the Chinese side, it would consult relevant Chinese departments and varsities to verify the list and indicate whether the identified students can travel to China to complete the course.

This coordination process would be carried out in a time-bound manner.

The Chinese side has also conveyed that eligible students should unconditionally abide by Covid-19 prevention measures, and agree to bear all expenses related to Covid-19 prevention measures by themselves.

Over 23,000 Indian students, primarily studying medicines, are stuck back home due to Covid-19 visas and flight bans by China in attempt to control spread of Covid-19.

MORE International ARTICLES

'Relieved': US health workers start getting COVID-19 vaccine

'Relieved': US health workers start getting COVID-19 vaccine
Shipments of precious frozen vials of vaccine made by Pfizer Inc. and its German partner BioNTech began arriving at hospitals around the country Monday.

'Relieved': US health workers start getting COVID-19 vaccine

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population
The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

WATCH: Why are Farmers Up in Arms Against India's Government ?

WATCH: Why are Farmers Up in Arms Against India's Government ?
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws. 

WATCH: Why are Farmers Up in Arms Against India's Government ?

White House still planning holiday parties, despite warnings

White House still planning holiday parties, despite warnings
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.

White House still planning holiday parties, despite warnings

3rd major COVID-19 vaccine shown to be effective and cheaper

3rd major COVID-19 vaccine shown to be effective and cheaper
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

3rd major COVID-19 vaccine shown to be effective and cheaper